Site records / Madhya Pradesh / FEI 3016268582

Par Formulations Private LimitedDhar, Madhya Pradesh

FDA-registered drug establishment in Dhar, Madhya Pradesh: analysis, label, manufacture, pack, sterilize. Registration valid to 31 Dec 2026. Record as observed 27 Sep 2026.

Inspections posted
1
Last inspection
May 2023 · NAI
Warning letters to this FEI
0
Import alerts at this address
0
US border refusals, 2 years
0
The site dossier

This site, graded.
Every fact sourced.

  • A grade from A to E on a registered ten-factor rubric, with the fact behind every factor
  • Every posted FDA citation, sorted into failure categories and set against Indian drug inspections
  • Warning-letter violations, numbered and labelled
  • Import-alert history rebuilt from the archive, each listing checked against this address
  • Border refusals by product, and the company's other sites, each graded
  • A hash of every source read, so the PDF can be checked against the record

On 2022–26 inspections the rubric never saw, grade E sites were classified OAI 26.5% of the time and grade A sites 4.0%.

PDF and data by email, usually within minutes, as of the day you buy. Card payment through Razorpay.

By buying you agree to the Terms and the refund policy: sales are final once delivered, except non-delivery.

Consultant plan · US$799 a month · five dossiers a month and watchlist alerts. Ask about the plan

Inspections

1 FDA inspection of this FEI, by end date; 1 with a posted classification.

  1. 12 May 2023NAI · No Action IndicatedDrug Quality Assurance · no citations posted

Warning letters and compliance actions

No FDA compliance action recorded against this FEI or letter to its name.

Import alerts in force

No listing in force under this firm's name.

Other registered sites of Par Health USA, LLC

Registration

FEI
3016268582
DUNS
877850053
Registered as
Par Formulations Private Limited
Registrant
Par Health USA, LLC
Address
Plot No. M 82 & M 83, Industrial Area, Dhar, Madhya Pradesh 454775, India (IND)
Operations
ANALYSIS, LABEL, MANUFACTURE, PACK, STERILIZE
Registration expires
31 Dec 2026

Sources: FDA drug establishment registrations, FDA Data Dashboard inspections and compliance actions, import-alert pages, warning letters, import refusals and the FDA reading room, as held in Counterfoil's point-in-time corpus. No matched action does not establish compliance, and FDA registration is not FDA approval. Sources and coverage.

COUNTERFOIL / CONTACT

Contact us.

How can we help?

Stored privately by Counterfoil. Your email is used only to respond to your enquiry.